Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (NCT07739394) titled 'Diazoxide in the Treatment of Type 1 Glycogenosis' on July 28.
Study Type: Observational
Primary Sponsor: Central Hospital, Nancy, France
Condition:
Glycogen Storage Disease Type I
Recruitment Status: Not recruiting
Date of First Enrollment: August 30, 2026
Target Sample Size: 15
To know more, visit https://clinicaltrials.gov/study/NCT07739394
Disclaimer: Curated by HT Syndication....